February 19, 2025

Recurrent Hyperpigmented Patches After GLP-1 Therapy: What's Your Diagnosis?

A 62-year-old female developed fixed drug eruption following semaglutide administration, highlighting the importance of recognizing unusual dermatologic reactions during treatment with glucagon-like peptide-1 receptor agonists.

Conexiant

February 17, 2025

Skin Metabolism and Exudation Limit Tattoo Ink Absorption, Study Finds

Researchers examined systemic absorption, metabolism, and excretion of tattoo ink tracers, providing evidence for a cutaneous first-pass effect and measuring systemic exposure levels.

Conexiant

February 14, 2025

Benzene Formation in Benzoyl Peroxide: Formulation’s Role

Researchers found that benzene formation in benzoyl peroxide products is influenced by formulation factors, with hot processing increasing levels and antioxidants reducing them.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

August 12, 2024

Study: U.S. Child Allergy Rates Shifted During Pandemic

A recent study investigated the prevalence of allergies and asthma among U.S. children during and before the COVID-19 pandemic, revealing changes in allergy prevalence and potential associations with pandemic-related lifestyle changes.

Conexiant

January 15, 2025

Bertagnolli to Exit NIH Director Role

NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.

Conexiant

October 11, 2024

Skin Pigmentation: Rethinking Drug Efficacy

With skin pigmentation influencing drug binding and potentially altering therapeutic outcomes, understanding melanin's role in pharmacokinetics is key to advancing equitable treatments.

Conexiant

November 26, 2024

Moisturizers in Dermatitis: Risk vs Reward

A recent review finds that moisturizers, commonly used in dermatitis care, may lead to adverse effects in children with eczema, emphasizing the need for moderation and personalized recommendations for their use. Published in the Journal of the American Academy of Dermatology.

Conexiant

November 13, 2024

Air Pollution Doubles Eczema Risk: Major Study

Individuals with eczema lived in areas with significantly higher PM2.5 concentrations, with each 10 μg/m3 increase in fine particulate matter associated with 2.66 times greater odds of developing the condition in this nationwide study of 286,766 adults.

Conexiant